Dentium: An Undervalued Corporate Activist Target + Likely Inclusion Candidate for KOSPI 200 in 2023
There is a growing probability that Dentium could be targeted by corporate activists to pressure the company to cancel treasury shares and provide...
718 Views
Dentium (145720 KS) Strength Without Substance
2Q will miss and full year guidance will be lowered. Eventually this company will sell its shares (22% of o/s) as a lifeline. Whether that be...
602 Views
Sejong Medical IPO Preview (Part 2) - Valuation Analysis
Sejong Medical Comparable Companies Valuation AnalysisWe are negative on the Sejong Medical IPO. The four major comps that the bankers used for...
380 Views
Genoray IPO Preview (Part 2) - Valuation Analysis
We are positive on the Genoray IPO. Our one year price target of the company is 25,944 won, which would represent nearly 27% higher than the high...
395 Views
Genoray IPO Preview (Part 1) - Better than Sejong Medical IPO?
Genoray is an IPO in Korea that is scheduled to be completed in May 2018. Genoray is a medical & dental imaging equipment maker in Korea. The...
388 Views